Hernandez Adrian F, Whellan David J, Stroud Sharon, Sun Jie Lena, O'Connor Christopher M, Jollis James G
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
J Am Coll Cardiol. 2004 Oct 6;44(7):1446-53. doi: 10.1016/j.jacc.2004.06.059.
The purpose of this study was to evaluate mortality and readmission rates of heart failure (HF) patients after major noncardiac surgery.
There is a lack of generalizable outcome data on HF patients undergoing major noncardiac surgery because previous studies have been limited to a few academic centers or have not focused on this group of patients.
Using the 1997 to 1998 Standard Analytic File 5% Sample of Medicare beneficiaries, we identified patients with HF who underwent major noncardiac surgery. A multivariable logistic regression model was used to provide adjusted mortality and readmission rates in patients after noncardiac surgery. Patients with coronary artery disease (CAD) and all other remaining patients (Control) who had similar surgery served as reference groups.
Of 23,340 HF patients and 28,710 CAD patients, 1,532 (6.56%) HF patients and 1,757 (6.12%) CAD patients underwent major noncardiac surgery. There were 44,512 patients in the Control group with major noncardiac surgery. After accounting for demographic characteristics, type of surgery, and comorbid conditions, the risk-adjusted operative mortality (death before discharge or within 30 days of surgery) was HF 11.7%, CAD 6.6%, and Control 6.2% (HF vs. CAD, p < 0.001; CAD vs. Control, p = 0.518). The risk-adjusted 30-day readmission rate was HF 20.0%, CAD 14.2%, and Control 11.0% (p < 0.001).
In patients 65 years of age and older, HF patients undergoing major noncardiac surgery suffer substantial morbidity and mortality despite advances in perioperative care, whereas patients with CAD without HF have similar mortality compared with a more general population.
本研究旨在评估接受非心脏大手术的心力衰竭(HF)患者的死亡率和再入院率。
由于既往研究局限于少数学术中心或未聚焦于这组患者,因此缺乏关于接受非心脏大手术的HF患者的可推广结局数据。
利用1997至1998年医疗保险受益人的标准分析文件5%样本,我们确定了接受非心脏大手术的HF患者。采用多变量逻辑回归模型来提供非心脏手术后患者的校正死亡率和再入院率。患有冠状动脉疾病(CAD)的患者以及接受类似手术的所有其他剩余患者(对照组)作为参照组。
在23340例HF患者和28710例CAD患者中,1532例(6.56%)HF患者和1757例(6.12%)CAD患者接受了非心脏大手术。对照组有44512例患者接受了非心脏大手术。在考虑人口统计学特征、手术类型和合并症后,风险校正后的手术死亡率(出院前或手术后30天内死亡)在HF患者中为11.7%,CAD患者中为6.6%,对照组中为6.2%(HF与CAD比较,p<0.001;CAD与对照组比较,p = 0.518)。风险校正后的30天再入院率在HF患者中为20.0%,CAD患者中为14.2%,对照组中为11.0%(p<0.001)。
在65岁及以上的患者中,尽管围手术期护理有所进步,但接受非心脏大手术的HF患者仍有较高的发病率和死亡率,而无HF的CAD患者与更一般人群相比死亡率相似。